Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2401 to 2415 of 8915 results

  1. Setmelanotide for treating obesity caused by a rare genetic disorder in children aged 2 to 5 [TSID11827]

    Topic prioritisation

  2. Subcutaneous olanzapine for treating schizophrenia [TSID12289]

    Topic prioritisation

  3. Menotrophin prefilled pen for treating anovulation or during controlled ovarian hyperstimulation [TSID12290]

    Topic prioritisation

  4. Transverse Tibial Transport

    Topic prioritisation

  5. Orforglipron for managing overweight and obesity ID6516

    In development Reference number: GID-TA11650 Expected publication date: TBC

  6. Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people of any age [ID6400]

    Awaiting development Reference number: GID-TA11509 Expected publication date: TBC

  7. Lifileucel for previously treated unresectable or metastatic melanoma ID3863

    In development Reference number: GID-TA10752 Expected publication date:  10 July 2026

  8. AHEAD implants for external ear prosthesis

    Topic prioritisation

  9. Intradiscal oxygen-ozone treatment of symptomatic lumbar disc herniation

    Topic prioritisation

  10. Insertion of Stoma Preservation Device

    Topic prioritisation

  11. Botulinum Toxin injection prior to Abdominal wall reconstruction

    Topic prioritisation

  12. Head injury (QS74) update

    In development Reference number: GID-QS10189 Expected publication date:  07 January 2027

  13. Osteoporosis

    In development Reference number: GID-QS10188 Expected publication date: TBC

  14. Tislelizumab with chemoradiation for treating localised oesophageal squamous cell cancer [ID5077]

    Awaiting development Reference number: GID-TA10971 Expected publication date: TBC